Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D culturesDirk Schumacher(German Cancer Research Center), Christian Regenbrecht(Itasca Consultants (Germany))PLoS GeneticsMarch 29, 201910.1371/journal.pgen.1008076Cited by 81SaveCiteExport RISWatch citationsRelated PapersMolecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors|Nature Communications|2017|348The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells|PLoS ONE|2014|99The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells|Oncogenesis|2017|65